SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.365
EU - Europa 4.453
AS - Asia 1.962
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
AF - Africa 1
Totale 16.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.349
DE - Germania 1.818
CN - Cina 1.230
UA - Ucraina 804
IT - Italia 584
TR - Turchia 416
RU - Federazione Russa 307
GB - Regno Unito 290
SG - Singapore 242
FI - Finlandia 202
SE - Svezia 192
PL - Polonia 146
FR - Francia 49
ID - Indonesia 39
BE - Belgio 20
CA - Canada 11
IE - Irlanda 8
RO - Romania 8
VN - Vietnam 8
BR - Brasile 7
CZ - Repubblica Ceca 7
NL - Olanda 7
EU - Europa 6
IN - India 5
HK - Hong Kong 4
IR - Iran 4
EC - Ecuador 3
MX - Messico 3
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
ES - Italia 2
JP - Giappone 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
GR - Grecia 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
VE - Venezuela 1
Totale 16.802
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.316
Fairfield 1.155
Chandler 1.111
Jacksonville 897
Houston 767
Ashburn 715
Ann Arbor 506
Wilmington 442
Seattle 432
Cambridge 359
Izmir 278
Beijing 268
Nanjing 263
Princeton 226
Addison 216
San Diego 152
Warsaw 146
Singapore 141
New York 138
Shanghai 137
Ferrara 131
Milan 125
Boardman 113
Shenyang 78
Hebei 70
Nanchang 70
Bremen 66
Washington 61
Dearborn 56
Changsha 46
Mountain View 46
Tianjin 46
Jiaxing 43
Jakarta 39
Falls Church 37
Redwood City 35
Helsinki 31
Jinan 31
Kunming 30
Los Angeles 28
Ningbo 24
London 23
Norwalk 23
Brussels 20
Guangzhou 20
Bologna 19
Des Moines 18
San Mateo 18
Zhengzhou 17
Orange 15
Tappahannock 15
Auburn Hills 14
Hangzhou 12
Taizhou 12
Indiana 11
Hefei 10
Philadelphia 10
Carrara 9
Dong Ket 8
Leawood 8
Monmouth Junction 8
Munich 8
Haikou 7
Lanzhou 7
Augusta 6
Changchun 6
Redmond 6
Brno 5
Castelnuovo Rangone 5
Ferrara di Monte Baldo 5
Verona 5
Walnut 5
Amsterdam 4
Ardabil 4
Chicago 4
Dallas 4
Hong Kong 4
Ottawa 4
San Francisco 4
Stockholm 4
Toronto 4
Treviso 4
Cattolica 3
Cordovado 3
Dublin 3
Fuzhou 3
Hounslow 3
Jinhua 3
Lusia 3
Napoli 3
Paris 3
Poggio Renatico 3
Porangatu 3
Reggio Emilia 3
Rome 3
Southwark 3
Terni 3
Voghera 3
Andover 2
Bentivoglio 2
Totale 11.318
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 235
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 160
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 154
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 152
Circadian profile of plasma calcitonin gene-related peptide in healthy man 146
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 146
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 137
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 133
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 131
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 131
null 130
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 127
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 125
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 125
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 124
Cerebral aneurysm and acromegaly: a case report 120
Pituitary side effects of old and new drugs. 119
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 118
null 118
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 118
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 116
In vitro testing of new somatostatin analogs on pituitary tumor cells 115
null 114
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 114
null 113
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 113
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 113
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 113
null 111
null 111
null 108
null 106
null 106
null 106
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 106
Growth hormone and skeletal muscle function 105
null 105
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 104
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 104
Growth hormone excess promotes breast cancer chemoresistance 104
null 104
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 104
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 103
null 103
null 102
null 102
null 102
null 101
null 101
null 100
null 100
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 99
null 98
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 97
null 97
Le alterazioni pressorie nell'acromegalia: fattori umorali 96
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 95
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 95
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 94
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 93
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 92
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 92
null 92
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 92
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 91
null 91
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 91
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 91
Diurnal rhythm of plasma catecholamines in acromegaly 90
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 89
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 89
Growth hormone induces chemoresistance in breast cancer cells 89
Ovarian tumors secreting insulin 89
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 88
null 88
null 88
Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications 87
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 87
Antiproliferative effects of somatostatin analogs in pituitary adenomas 86
Prevalence of hypopituitarismin patients with cerebrovascular diseases 85
null 85
Glucose metabolism alterations in acromegaly 85
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 85
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 85
null 84
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 83
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 83
Delta opioid receptor involvement in endocrine pathophysiology 82
Occurrence of pituitary dysfunction following traumatic brain injury 82
Pattern of Growth Hormone secretion in closed head injured patients 82
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 82
Systemic illness 81
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 81
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 81
null 81
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study 81
Functional hypothalamic and drug-induced amenorrhea: an overview 81
Cerebrovascular disease and GH-IGF-i axis function 81
null 81
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 80
Totale 10.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.294
Totale 76.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.128 547 92 87 447 184 397 235 308 210 375 195 51
2020/20212.021 187 145 119 256 72 212 64 235 66 269 288 108
2021/20221.981 58 208 114 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/202557 57 0 0 0 0 0 0 0 0 0 0 0
Totale 17.090